Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Skipper

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer Chemotherapy Reports|June 1, 1970
The "sensitivity" of resting and dividing cellsR F Pittillo, F M Schabel, H E Skipper
Klinika Oczna|January 1, 1971
The "sensitivity" of resting and dividing cellsR F Pittillo, F M Schabel, H E Skipper
Seminars in Hematology|July 1, 1978
Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cellsH E Skipper, F M Schabel, H H Lloyd
Cancer Chemotherapy Reports. Part 2|March 1, 1974
Combination chemotherapy for spontaneous AKR lymphomaF M Schabel, H E Skipper, M W Trader, et al.
European Journal of Cancer|January 1, 1980
Concepts for controlling drug-resistant tumor cellsF M Schabel, H E Skipper, M W Trader, et al.
Cancer Chemotherapy Reports|June 1, 1972
Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971H E Skipper, F M Schabel, M W Trader, et al.
Cancer Treatment Reports|October 1, 1983
Establishment of cross-resistance profiles for new agentsF M Schabel, H E Skipper, M W Trader, et al.
Medical and Pediatric Oncology|January 1, 1982
Drug control of Ara-C-resistant tumor cellsF M Schabel, H E Skipper, M W Trader, et al.
Cancer Chemotherapy Reports|December 1, 1970
Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedulesH E Skipper, F M Schabel, L B Mellett, et al.
Cancer Chemotherapy Reports|August 1, 1972
A quick reference chart on cross resistance between anticancer patientsH E Skipper, D J Hutchison, F M Schabel, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Chemotherapy Reports|June 1, 1970
The "sensitivity" of resting and dividing cellsR F Pittillo, F M Schabel, H E Skipper
Klinika Oczna|January 1, 1971
The "sensitivity" of resting and dividing cellsR F Pittillo, F M Schabel, H E Skipper
Seminars in Hematology|July 1, 1978
Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cellsH E Skipper, F M Schabel, H H Lloyd
Cancer Chemotherapy Reports. Part 2|March 1, 1974
Combination chemotherapy for spontaneous AKR lymphomaF M Schabel, H E Skipper, M W Trader, et al.
European Journal of Cancer|January 1, 1980
Concepts for controlling drug-resistant tumor cellsF M Schabel, H E Skipper, M W Trader, et al.
Cancer Chemotherapy Reports|June 1, 1972
Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971H E Skipper, F M Schabel, M W Trader, et al.
Cancer Treatment Reports|October 1, 1983
Establishment of cross-resistance profiles for new agentsF M Schabel, H E Skipper, M W Trader, et al.
Medical and Pediatric Oncology|January 1, 1982
Drug control of Ara-C-resistant tumor cellsF M Schabel, H E Skipper, M W Trader, et al.
Cancer Chemotherapy Reports|December 1, 1970
Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedulesH E Skipper, F M Schabel, L B Mellett, et al.
Cancer Chemotherapy Reports|August 1, 1972
A quick reference chart on cross resistance between anticancer patientsH E Skipper, D J Hutchison, F M Schabel, et al.
Pageof 3